News | Radiology Business | April 10, 2023

ASTRO issued the following statement regarding the recent final rule from the CMS that revises the Medicare Advantage prior authorization process 

ASTRO issued the following statement regarding the recent final rule from the CMS that revises the Medicare Advantage prior authorization process

Getty Images


April 10, 2023 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Board of Directors Chair, in response to the recent final rule from the Centers for Medicare and Medicaid Services (CMS) that revises the Medicare Advantage prior authorization process: 

"ASTRO applauds this final rule from CMS, which is a major step in reforming the broken, burdensome prior authorization system. Changes that increase transparency, reduce care disruptions and improve coverage criteria guidelines used by Medicare Advantage plans will bring much-needed relief to physicians and our patients with cancer. We appreciate that CMS addressed an array of concerns raised by ASTRO, the radiation oncology community and physicians nationwide. 

The delays and interference associated with prior authorization are unnecessarily burdensome for radiation oncologists, who face the most significant prior authorization hurdles of any medical specialty. Based on ASTRO research, 90% of radiation oncology practices report that prior authorization delayed their patients’ access to life-saving cancer treatments, and a majority say the average delay lasts a week or longer. 

While we are optimistic about these reforms, we also urge CMS to hold insurance companies accountable for following the new requirements. We also eagerly await additional rulemaking to address the substantial administrative burden created by prior authorization. Further changes such as streamlining the approval process and establishing determination timelines will be necessary to truly repair this broken system.” 

For more information: www.astro.org 

Find more ASTRO23 content here 


Related Content

News | Treatment Planning

November 26, 2023 — TeleDaaS, PLLC, a leading dosimetry-as-a-service provider, made its official debut today at the ...

Time November 26, 2023
arrow
News | RSNA

November 22, 2023 — GE HealthCare is preparing to showcase its Artificial Intelligence (AI)-enabled solutions at the ...

Time November 22, 2023
arrow
News | RSNA

November 22, 2023 — ScreenPoint Medical has announced that its Transpara breast AI has surpassed 5 million mammograms ...

Time November 22, 2023
arrow
News | Computed Tomography (CT)

November 22, 2023 — Lung cancer is one of the world’s silent killers. By the time patients experience symptoms, the ...

Time November 22, 2023
arrow
News | Breast Imaging

November 21, 2023 —iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and CancerIQ ...

Time November 21, 2023
arrow
News | Breast Imaging

November 20, 2023 — The American Society for Radiation Oncology (ASTRO) issued a clinical guideline on partial breast ...

Time November 20, 2023
arrow
News | ARRS

November 16, 2023 — The American Roentgen Ray Society (ARRS) is pleased to announce Francis Baffour of Mayo Clinic in ...

Time November 16, 2023
arrow
News | Artificial Intelligence

November 15, 2023 — The 2023 Radiological Society of North America (RSNA) Alexander R. Margulis Award for Scientific ...

Time November 15, 2023
arrow
News | Radiology Imaging

November 15, 2023 — U.S. Electronics, Inc. (USEI), a reputable medical device manufacturing company with over 25 years ...

Time November 15, 2023
arrow
News | Information Technology

November 14, 2023 — To help provide clinicians a comprehensive workflow, GE HealthCare is working towards the seamless ...

Time November 14, 2023
arrow
Subscribe Now